Clinical and Radiographic Evaluation of Indirect Pulp Capping Using Platelet Rich Fibrin Versus Mineral Trioxide Aggregate in Deep Carious Molars: a Randomized Controlled Trial

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age20-40
SponsorCairo University

About this trial

The aim of this study is the clinical and radiographic evaluation of (Platelet-Rich Fibrin (PRF) versus Mineral Trioxide Aggregate (MTA) in indirect pulp capping when used with deep carious molars over 1 year follow up.

Eligibility criteria

Qualifiers

o Patients with asymptomatic deep carious molars.

Patients with clinically and radiographically confirmed deep carious lesions that do not exhibit spontaneous pain.

Permanent molars only.

Teeth with intact or minimally restored occlusal surfaces (i.e., no extensive restorations or fractures).

Disqualifiers

o Patients with systemic conditions affecting bone or tissue healing (e.g., uncontrolled diabetes, osteoporosis, immunosuppressed conditions).

Pregnant or lactating women (if applicable to your study).

Teeth with pulp exposure or necrotic pulp.

Presence of symptomatic irreversible pulpitis (e.g., spontaneous pain, lingering pain).

Trial design

Treatments tested in this trial

  • MTA
  • PRF

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators